starting retatrutide dose Dose: Full Dosing Guide and What to Expect how much retatrutide to take

Contact your GP if headaches are frequent, severe, or interfere with daily activities

The FDA indication for GLP-1 medications for weight management begins at a BMI of 30, or 27 with qualifying comorbidities

Increased heart rate: Some patients may experience an increase in heart rate, especially shortly after injection

Any part of the oral mucosa may be affected, but particularly the buccal mucosa, and although they are usually solitary, there are sometimes several oral melanotic macules

To qualify for Semaglutide GLP-1 weight loss treatment, a BMI of 30 or higher (indicating obesity) or a BMI of 27 or higher with weight-related health conditions is typically required